ImmunityBio, Inc. (IBRX) Current Reports & Earnings Releases
Upcoming
- 2026-11-04 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-04 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-07-30 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-06-10 | 8-K | Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2026-05-18 | 8-K | Material Agreement, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-05-07 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-04-09 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-04-06 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-03-31 | 8-K | Material Agreement, Direct Financial Obligation, Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2026-02-23 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-02-18 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2026-01-26 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2026-01-15 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-01-14 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-12-29 | 8-K | Material Agreement, Other Events, Financial Statements & Exhibits | SEC |
| 2025-12-15 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2025-12-12 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-11-05 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-08-08 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-08-05 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-07-25 | 8-K | Material Agreement, Results of Operations, Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2025-06-20 | 8-K | Officer / Director Changes, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2025-05-12 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-05-05 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-04-15 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-04-08 | 8-K | Material Agreement, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-03-19 | 8-K | Auditor Change, Financial Statements & Exhibits | SEC |
| 2025-03-03 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-02-13 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2025-02-07 | 8-K | Officer / Director Changes | SEC |
| 2024-12-11 | 8-K | Material Agreement, Other Events, Financial Statements & Exhibits | SEC |
| 2024-12-10 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-11-19 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-11-12 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-07-18 | 8-K | Material Agreement | SEC |
| 2024-06-12 | 8-K | Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2024-04-23 | 8-K | Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2024-02-26 | 8-K | Officer / Director Changes, Item 5.05 | SEC |
| 2024-01-02 | 8-K | Material Agreement, Direct Financial Obligation, Unregistered Sales, Other Events, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.